Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Psoriasis: assessment and management

Clinical guideline
Reference number: CG153
Published: 24 October 2012
Last updated: 01 September 2017

History

Surveillance consultation

Surveillance consultation
Surveillance review proposal (PDF 1.14 MB)

Published:

27 March 2017
Comments form (MSWord 27 KB)

Published:

27 March 2017

Stakeholder list updated

Stakeholder list (PDF 40 KB)

Published:

22 March 2017

Review documents

Surveillance review document (PDF 179 KB)

Published:

19 November 2014

Other information

Evidence update (PDF 554 KB)

Published:

01 November 2014

Background information

Press release information

Guideline development and consultation

Guideline development and consultation
Guideline Equality Impact Assessment form (PDF 336 KB)

Published:

23 September 2013
Consultation comments table (PDF 1.2 MB)

Published:

24 October 2012
Guideline consultation information
LETR for topical treatments of trunk and limbs - correction to section 8.5 (PDF 370 KB)

Published:

31 May 2012
Full guideline (PDF 8.5 MB)

Published:

10 May 2012
NICE guideline (PDF 349 KB)

Published:

10 May 2012
Comments proforma (MSWord 45 KB)

Published:

10 May 2012
Appendices information
Appendices (PDF 19.61 MB)

Published:

10 May 2012
Confidentiality agreement (MSWord 52 KB)

Published:

11 May 2012
Appendices information
List of stakeholders (PDF 22 KB)

Published:

06 June 2012
Guideline development group minutes
GDG 13 minutes 20.02.12 (PDF 60 KB)

Published:

04 September 2012
GDG 8 & 9 minutes 10.10.11 & 11.10.11 (PDF 33 KB)

Published:

15 November 2011
GDG 7 minutes 06.09.11 (PDF 33 KB)

Published:

02 November 2011
GDG 6 minutes 13.07.11 (PDF 32 KB)

Published:

06 October 2011
GDG 5 minutes 20.05.11 (PDF 60 KB)

Published:

01 September 2011
GDG 4 minutes 12.04.11 (PDF 61 KB)

Published:

01 September 2011
GDG 3 minutes 17.03.11 (PDF 63 KB)

Published:

01 September 2011
GDG 2 minutes 17.02.11 (PDF 60 KB)

Published:

01 September 2011
GDG 1 minutes: 20.01.11 (PDF 44 KB)

Published:

04 March 2011

Economic plan, review questions and search strategies

Economic plan, review questions and search strategies
Economic plan (PDF 59 KB)

Published:

19 April 2012
Search strategies (PDF 955 KB)

Published:

19 April 2012
Protocol (PDF 602 KB)

Published:

19 April 2012
Review questions (PDF 309 KB)

Published:

19 April 2012

Amended remit October 2010

Amended remit October 2010 (PDF 84 KB)

Published:

17 November 2010

Remit

Remit (PDF 17 KB)

Published:

12 November 2009

Scoping workshop, consultation and final scope

Scoping workshop, consultation and final scope
Scoping Equality Impact Assessment form (PDF 209 KB)

Published:

23 September 2013
GDG members (PDF 5 KB)

Published:

24 January 2011
Scoping workshop notes (PDF 111 KB)

Published:

23 December 2010
Stakeholder comments table (PDF 251 KB)

Published:

23 December 2010
Final scope (PDF 68 KB)

Published:

23 December 2010
Scoping workshop notes (MSWord 116 KB)

Published:

03 September 2010
Draft scope consultation information
Draft scope (PDF 83 KB)

Published:

03 September 2010
Comments proforma (MSWord 44 KB)

Published:

03 September 2010
Incontinence in neurological disease: stakeholder list (PDF 75 KB)

Published:

16 May 2011

National Clinical Guideline Centre for Acute and Chronic Conditions

National Clinical Guideline Centre for Acute and Chronic Conditions information